Researchers have been excited about Retatrutide , a novel dual agonist showing remarkable results in early trials for size loss . It acts by modulating both hormones : GLP-1 and GIP, these, when activated https://deweyiyyf272194.bloginwi.com/74574207/a-new-possibility-for-weight-loss